Literature DB >> 20975816

Missing the sweet spot disengagement in schizophrenia.

Richard S E Keefe1.   

Abstract

The extent to which an individual engages in a cognitive task is associated with performance in laboratory settings(1) and a variety of domains of functioning, such as athletic activity and artistic expression.(2) The neural circuitry associated with task engagement is in the process of being elucidated by cognitive neuroscience investigations. These newly acquired data provide an opportunity to understand the cognitive, social, and functional disabilities that lie at the core of dysfunction in patients with schizophrenia. This article describes the importance of task engagement in human functioning, its impairment in schizophrenia, and the possibility that disengagement during late adolescence may herald future development of schizophrenia.(3,4) Since treatment studies suggest that improvement in this aspect of cognitive functioning has the potential to improve the functioning of patients with schizophrenia in various domains, it is possible that these improvements may be mediated by improved engagement with external processes, including social processes and patient-clinician relationships, leading to improved therapeutic alliance and increased treatment adherence.

Entities:  

Keywords:  cognition; disengagement; schizophrenia; task engagement

Year:  2006        PMID: 20975816      PMCID: PMC2958865     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  20 in total

1.  Physiological characteristics of capacity constraints in working memory as revealed by functional MRI.

Authors:  J H Callicott; V S Mattay; A Bertolino; K Finn; R Coppola; J A Frank; T E Goldberg; D R Weinberger
Journal:  Cereb Cortex       Date:  1999 Jan-Feb       Impact factor: 5.357

2.  Functional anatomical correlates of controlled and automatic processing.

Authors:  J M Jansma; N F Ramsey; H A Slagter; R S Kahn
Journal:  J Cogn Neurosci       Date:  2001-08-15       Impact factor: 3.225

3.  The remediation of problem-solving skills in schizophrenia.

Authors:  A Medalia; N Revheim; M Casey
Journal:  Schizophr Bull       Date:  2001       Impact factor: 9.306

4.  Activation of human presupplementary motor area in learning of sequential procedures: a functional MRI study.

Authors:  O Hikosaka; K Sakai; S Miyauchi; R Takino; Y Sasaki; B Pütz
Journal:  J Neurophysiol       Date:  1996-07       Impact factor: 2.714

5.  Transition of brain activation from frontal to parietal areas in visuomotor sequence learning.

Authors:  K Sakai; O Hikosaka; S Miyauchi; R Takino; Y Sasaki; B Pütz
Journal:  J Neurosci       Date:  1998-03-01       Impact factor: 6.167

6.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

7.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

Review 8.  Structural and functional brain development and its relation to cognitive development.

Authors:  B J Casey; J N Giedd; K M Thomas
Journal:  Biol Psychol       Date:  2000-10       Impact factor: 3.251

9.  A 15O-H2O PET study of meditation and the resting state of normal consciousness.

Authors:  H C Lou; T W Kjaer; L Friberg; G Wildschiodtz; S Holm; M Nowak
Journal:  Hum Brain Mapp       Date:  1999       Impact factor: 5.038

10.  Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors.

Authors:  A P Morrison; R P Bentall; P French; L Walford; A Kilcommons; A Knight; M Kreutz; S W Lewis
Journal:  Br J Psychiatry Suppl       Date:  2002-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.